Trial: Drug delays relapse in Alzheimer’s disease agitation … Study finds neflamapimod effective for dementia with Lewy bodies … Biogen shares trial data for tau-targeting Alzheimer’s drug …...
Falling by the wayside
Oct 24, 2023
This month’s column invokes several previous columns, one about medications and the other about knowing if we know what we don’t know. A recent medical journal article concluded that falls in...
Study: Antipsychotic, psychoactive drug use drops in older adults post-surgery in hospital settings
Sep 11, 2023
Use of antipsychotic and psychoactive drugs following surgery generally fell in various settings among those experiencing postoperative delirium, according to a study published in the Journal of the American...
Healthcare workers at high risk of drug overdose, study finds
Aug 09, 2023
Healthcare workers including nurses and behavioral health workers have two times the risk for drug overdose compared to people who don’t work in the field, a new study shows.
Battle over Alzheimer’s drug coverage is hardly a no-brainer
Feb 26, 2023
Well, it looks like we have a good old fashioned war of words developing over Alzheimer’s drug coverage. It’s a battle well worth watching.
Meds with potential to transform senior care make Drugs to Watch report
Jan 19, 2023
A number of pre-launch drugs are on track to address unmet patient needs in dementia, Parkinson’s disease and other ailments, say the authors of a 2023 report.
With education and a doc’s OK, most seniors agree to deprescribe unneeded meds: study
Jan 10, 2023
Seniors are willing to take their doctor’s advice to discontinue an unneeded medication after viewing an educational video, investigators say.
Antiepileptic drug prescriptions increasing in nursing homes: study
Nov 11, 2022
Clinicians appear to be relying on antiepileptics to address residents’ chronic pain and behavioral symptoms. Other drug prescriptions are meanwhile declining, MDS and Medicare data show.
Polypharmacy rises before a dementia diagnosis: study
Oct 13, 2022
Drug prescriptions increase in the 20 years before a patient’s dementia diagnosis, and prescribing patterns begin to hone in on particular medical conditions, a new study finds.
New program will test clinician awareness of drugs known to increase falls in dementia
Aug 23, 2022
The Stop-Falls-D program uses prompts to help reduce the use of drugs that affect the central nervous system, such as sleeping pills, anti-anxiety medications and pain relievers, in patients with dementia.